Early intervention with COVID-19 therapeutics (monoclonal antibodies and antivirals) can reduce the risk of severe illness and hospitalization for people with COVID-19 who are at high risk of developing more serious illness. If patients think they may qualify, please instruct them to speak to their health care providers or access this free telehealth service from the Washington State Department of Health (DOH) to determine their eligibility for COVID-19 therapeutics.
Visit the DOH webpage for more information on specific COVID-19 therapeutics. (Tina Seery)
